Alector, Inc. Current Assets
Alector, Inc. (ALEC) had Current Assets of $180.09 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $180.09M.
- 2026-03-31: Assets, Current $215.08M.
- 2025-12-31: Assets, Current $266.45M.
- 2025-09-30: Assets, Current $300.38M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $180.09M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $215.08M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $266.45M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $300.38M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $319.18M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $366.65M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $424.82M 10-K · filed 2026-02-25 |
| 2024-09-30 | $469.36M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $519.70M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $581.39M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $565.81M 10-K · filed 2025-02-26 |
| 2023-09-30 | $613.15M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $647.99M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $686.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $726.43M 10-K · filed 2024-02-27 |
| 2022-09-30 | $774.96M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $827.02M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $890.93M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $749.71M 10-K · filed 2023-02-28 |
| 2021-09-30 | $788.02M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $329.33M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $374.74M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $421.51M 10-K · filed 2022-02-24 |
| 2020-09-30 | $470.01M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $510.09M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $556.20M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $357.44M 10-K · filed 2021-02-25 |
| 2019-09-30 | $385.48M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $414.60M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $442.11M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $293.18M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |